NASDAQ:ARAY
Accuray Incorporated Stock News
$2.14
-0.0700 (-3.17%)
At Close: Apr 19, 2024
Accuray Incorporated (ARAY) Q1 2024 Earnings Call Transcript
10:46pm, Tuesday, 07'th Nov 2023
Accuray Incorporated (NASDAQ:ARAY ) Q1 2024 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pe
Compared to Estimates, Accuray (ARAY) Q1 Earnings: A Look at Key Metrics
10:32pm, Tuesday, 07'th Nov 2023
The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street esti
With Chinese Type B Approval In Hand, 'Now Or Never' Approaches For Accuray
12:23am, Friday, 06'th Oct 2023
Accuray's China JV recently received approval to sell its locally-produced Tomo C rad-onc system for China's Type B market - an opportunity that management estimates at $3B over 5 years. Management ha
Accuray's (ARAY) Tomo C Radiation System Gets Approval in China
09:01am, Thursday, 05'th Oct 2023
Accuray's (ARAY) Tomo C radiation therapy system will enable medical care teams to provide personalized and highly precise treatments.
Accuray's (ARAY) New Offering to Boost Radiation Treatment Plans
12:46pm, Tuesday, 03'rd Oct 2023
Accuray's (ARAY) latest offering is likely to improve radiation treatment.
Why Is Accuray (ARAY) Down 15.2% Since Last Earnings Report?
12:47pm, Friday, 08'th Sep 2023
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
Accuray Incorporated - Impressive Growth As Orders Expands
02:36am, Saturday, 19'th Aug 2023
Accuray Incorporated has shown impressive growth in its share price and revenues, making it an attractive investment opportunity in the healthcare equipment market. The company is becoming a leader in
Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod
10:55am, Tuesday, 15'th Aug 2023
Accuray's (ARAY) latest regulatory approval is likely to improve breast cancer treatment.
New Strong Sell Stocks for August 11th
10:02am, Friday, 11'th Aug 2023
NGLOY, ARAY and BANR have been added to the Zacks Rank #5 (Strong Sell) List on August 11, 2023.
Accuray (ARAY) Q4 Earnings and Revenues Lag Estimates
01:00pm, Thursday, 10'th Aug 2023
Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances.
Accuray (ARAY) Reports Q4 Earnings: What Key Metrics Have to Say
09:58pm, Wednesday, 09'th Aug 2023
Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street e
Accuray (ARAY) Hits 52-Week High: What's Aiding the Stock?
11:42am, Wednesday, 24'th May 2023
Investors are optimistic about Accuray's (ARAY) solid product portfolio.
Accuray (ARAY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10:45pm, Wednesday, 26'th Apr 2023
Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street
Accuray (ARAY) Q3 Earnings and Revenues Beat Estimates
07:45pm, Wednesday, 26'th Apr 2023
Accuray (ARAY) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.01 per share a year ago.
Here's Why You Should Retain Accuray (ARAY) Stock for Now
09:59am, Monday, 20'th Mar 2023
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
